Citigroup’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $459K | Buy |
23,458
+7,575
| +48% | +$225K | ﹤0.01% | 3599 |
|
|
2025
Q4 | $494K | Buy |
15,883
+9,241
| +139% | +$253K | ﹤0.01% | 3577 |
|
|
2025
Q3 | $143K | Sell |
6,642
-36,350
| -85% | -$656K | ﹤0.01% | 4129 |
|
|
2025
Q2 | $601K | Sell |
42,992
-92,422
| -68% | -$1.25M | ﹤0.01% | 3517 |
|
|
2025
Q1 | $1.83M | Sell |
135,414
-507
| -0.4% | -$8.64K | ﹤0.01% | 2781 |
|
|
2024
Q4 | $2.61M | Buy |
135,921
+89,704
| +194% | +$1.95M | ﹤0.01% | 2591 |
|
|
2024
Q3 | $1.05M | Buy |
46,217
+19,014
| +70% | +$311K | ﹤0.01% | 3229 |
|
|
2024
Q2 | $354K | Sell |
27,203
-320,710
| -92% | -$4.44M | ﹤0.01% | 3602 |
|
|
2024
Q1 | $6.09M | Buy |
347,913
+263,626
| +313% | +$5.11M | ﹤0.01% | 1568 |
|
|
2023
Q4 | $1.84M | Sell |
84,287
-26,022
| -24% | -$411K | ﹤0.01% | 2312 |
|
|
2023
Q3 | $1.69M | Buy |
110,309
+30,564
| +38% | +$583K | ﹤0.01% | 2107 |
|
|
2023
Q2 | $1.9M | Sell |
79,745
-88,356
| -53% | -$2.27M | ﹤0.01% | 2266 |
|
|
2023
Q1 | $4.28M | Buy |
168,101
+110,746
| +193% | +$3.55M | ﹤0.01% | 1580 |
|
|
2022
Q4 | $1.68M | Buy |
57,355
+3,977
| +7% | +$91.6K | ﹤0.01% | 2182 |
|
|
2022
Q3 | $1.09M | Buy |
53,378
+51,514
| +2,764% | +$926K | ﹤0.01% | 2645 |
|
|
2022
Q2 | $22K | Sell |
1,864
-26,276
| -93% | -$353K | ﹤0.01% | 4952 |
|
|
2022
Q1 | $520K | Buy |
28,140
+13,256
| +89% | +$255K | ﹤0.01% | 3473 |
|
|
2021
Q4 | $294K | Buy |
+14,884
| New | +$277K | ﹤0.01% | 4134 |
|
|
2020
Q1 | – | Sell |
-195
| Closed | -$1K | – | 7790 |
|
|
2019
Q4 | $1K | Hold |
195
| – | – | ﹤0.01% | 7622 |
|
|
2019
Q3 | $2K | Sell |
195
-331
| -63% | -$7.32K | ﹤0.01% | 7557 |
|
|
2019
Q2 | $16K | Buy |
526
+63
| +14% | +$2.53K | ﹤0.01% | 7170 |
|
|
2019
Q1 | $19K | Buy |
463
+6
| +1% | +$271 | ﹤0.01% | 6993 |
|
|
2018
Q4 | $21K | Sell |
457
-19
| -4% | -$1.1K | ﹤0.01% | 6860 |
|
|
2018
Q3 | $40K | Buy |
476
+214
| +82% | +$20.2K | ﹤0.01% | 6709 |
|
|
2018
Q2 | $25K | Buy |
262
+107
| +69% | +$11.3K | ﹤0.01% | 6811 |
|
|
2018
Q1 | $17K | Buy |
155
+147
| +1,838% | +$16K | ﹤0.01% | 6838 |
|
|
2017
Q4 | $1K | Buy |
+8
| New | +$1.02K | ﹤0.01% | 7500 |
|
|
2017
Q3 | – | Sell |
-1,556
| Closed | -$302K | – | 7454 |
|
|
2017
Q2 | $302K | Buy |
+1,556
| New | +$263K | ﹤0.01% | 4449 |
|
|
2016
Q1 | – | Sell |
-2
| Closed | – | – | 7792 |
|
|
2015
Q4 | $0 | Buy |
+2
| New | +$385 | ﹤0.01% | 7891 |
|
|
2015
Q2 | – | Sell |
-6
| Closed | -$3K | – | 7777 |
|
|
2015
Q1 | $3K | Buy |
6
+4
| +200% | +$2.31K | ﹤0.01% | 6879 |
|
|
2014
Q4 | $1K | Buy |
+2
| New | +$1.44K | ﹤0.01% | 7001 |
|
Other funds holding VRDN
BG
VCM
FFM
VA
PBA
